Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis
- PMID: 24041830
- DOI: 10.1016/j.jneuroim.2013.08.012
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis
Abstract
Multiple sclerosis (MS) is a chronic neuroinflammatory disease of the central nervous system that leads to demyelination and neurodegeneration. VIP and PACAP are structurally related neuropeptides with neuroprotective and anti-inflammatory activities. To evaluate VIP and PACAP-38 in plasma and CSF in humans in correlation with IL-6, IL-10 and TNFα, we compared 20 MS individuals with 27 healthy controls. In MS, a decrease in PACAP-38 in CSF and a decrease in plasma IL-6 concentration were seen. A positive correlation between plasma VIP and plasma IL-6 was identified. We conclude that VIP and PACAP may influence the course of MS.
Keywords: IL-10; IL-6; Multiple sclerosis; PACAP; TNFα; VIP.
© 2013.
Similar articles
-
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.J Immunol. 1999 Feb 1;162(3):1707-16. J Immunol. 1999. PMID: 9973433
-
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression.J Immunol. 1999 Oct 1;163(7):3629-35. J Immunol. 1999. PMID: 10490956
-
Neuropeptides shaping the central nervous system development: Spatiotemporal actions of VIP and PACAP through complementary signaling pathways.J Neurosci Res. 2016 Dec;94(12):1472-1487. doi: 10.1002/jnr.23915. Epub 2016 Sep 26. J Neurosci Res. 2016. PMID: 27717098 Review.
-
Significance of serum VIP and PACAP in multiple sclerosis: an exploratory case-control study.Neurol Sci. 2022 Apr;43(4):2621-2630. doi: 10.1007/s10072-021-05682-5. Epub 2021 Oct 26. Neurol Sci. 2022. PMID: 34698942
-
Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis.Int J Mol Sci. 2022 Apr 26;23(9):4788. doi: 10.3390/ijms23094788. Int J Mol Sci. 2022. PMID: 35563181 Free PMC article. Review.
Cited by
-
Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service.J Clin Med. 2019 Sep 18;8(9):1488. doi: 10.3390/jcm8091488. J Clin Med. 2019. PMID: 31540472 Free PMC article. Review.
-
Differential Expression of PACAP/VIP Receptors in the Post-Mortem CNS White Matter of Multiple Sclerosis Donors.Int J Mol Sci. 2024 Aug 14;25(16):8850. doi: 10.3390/ijms25168850. Int J Mol Sci. 2024. PMID: 39201536 Free PMC article.
-
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases.Front Cell Neurosci. 2020 Jul 17;14:221. doi: 10.3389/fncel.2020.00221. eCollection 2020. Front Cell Neurosci. 2020. PMID: 32765225 Free PMC article.
-
Correlation of Decreased Serum Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Levels With Non-motor Symptoms in Patients With Parkinson's Disease.Front Aging Neurosci. 2021 Sep 8;13:689939. doi: 10.3389/fnagi.2021.689939. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34566619 Free PMC article.
-
Role of endocrine PACAP in age-related diseases.Front Endocrinol (Lausanne). 2023 Mar 9;14:1118927. doi: 10.3389/fendo.2023.1118927. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36967746 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical